The largest database of trusted experimental protocols

11 protocols using cd20 pe

1

Flow Cytometric Analysis of B Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
We assessed the expression of inhibitory and trafficking receptors on B cell subpopulations using multi-color flow cytometry using the gating strategy presented in Figure S1 in Supplementary Material. Conjugated mouse antihuman monoclonal mAb specific for the following markers were employed: FITC CD22, PE CD27, PE CD20, PE CD85J, PE-Cy7 CCR6, APC-H7 CD19, and PerCP-Cy5.5 CXCR3 all from (BD Pharmingen™, UK); PE FCRL4, PE-y7 CD62L, and PerCP-Cy5.5 CD11c from (BioLegend, San Diego, CA, USA); APC CD21 from (eBioscience, UK) and Qdot 605 CD10 from (Invitrogen™, USA). Cells were acquired on BD LSRFortessa cell analyzer (BD, Bioscience, USA) and data were analyzed using FlowJo software (Treestar, San Carlos, CA, USA). Median fluorescence intensity (MFI) was used to compare the expression of inhibitory and chemokine receptors in the different study groups.
+ Open protocol
+ Expand
2

Alloantibody Detection by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Alloantibody production was retrospectively assessed by flow cytometric crossmatch of donor PBMCs with serially collected recipient serum samples. Donor PBMCs were coated with ChromPure goat IgG (Jackson ImmunoResearch, West Grove, PA) and incubated with recipient serum. Cells were stained with FITC-labeled anti-monkey IgG (KPL, Inc. Gaithersburg, MD), PE CD20 (BD Pharmingen), and PerCP CD3 (BD Pharmingen). A two-fold increase in mean fluorescence intensity from pre-transplant values was used to define alloantibody positivity, with all positive shifts being greater than 100 shift in mean fluorescence intensity.
+ Open protocol
+ Expand
3

Plasmablast B cell isolation protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh PBMC were used to sort human plasmablast B cells as described before [12 (link)]. Cells were stained with the following antibody panel: CD3 BV421 (BD Biosciences), CD19 APC (BD Biosciences), CD27 FITC (BD Biosciences), CD38 PE Cy7 (BD Biosciences), CD20 PE (BD Biosciences). Plasmablasts were defined as CD3/CD19+/CD27+/ CD38+/CD20 and sorted on a FACS Jazz sorter in single cell mode into a 96 well plate.
+ Open protocol
+ Expand
4

Flow Cytometric Analysis of B Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
B cell subsets were identified with following anti-human antibodies: CD19 PE Cy5.5, anti-IgM APC, CD27 FITC, anti-IgD PerCP Cy7, CD21 PerCP Cy7, FCμR PE (clone HM14), mouse IgG1κPE (isotype), CD20 PE and CD43 APC, all from BD Pharmingen (San Jose, California). TLR2 (Pam3CSK4), CpG (ODN 2006) were purchased from InvivoGen (San Diego, California). In Initial experiments, HM14 mAb monoclonal antibody against FcμR [7 (link)] provided by Kubagawa was used. Thereafter, commercial antibodies (same clone) were used.
+ Open protocol
+ Expand
5

Isolation and Expansion of Donor NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh healthy donor NK cells were purchased from AllCells with either CD56 positive selection or CD56 negative selection (Allcells, cat#PB012-P or PB012-N). For 2D migration experiments, NK cells were enriched from peripheral blood using RosetteSep (StemCell Technologies) from healthy adult donors. T cells, B cells and monocytes were isolated from PBMCs (AllCells) using Mojosort magnetic cell separation system from Biolegend via CD3 positivity (Biolegend, cat#480133), CD19 positivity (Biolegend, cat#480105), CD14 positivity (Biolegend, cat#480093). PBMC purity was assessed using flow cytometry: CD3-APC (Biolegend, cat#300411), CD14-BV421 (Biolegend, cat#325627), CD45-FITC (BD Bioscience, cat#347463), CD56-PE (BD Bioscience, cat#555516), CD20-PE (BD Bioscience, cat#555623). For donor NK cell lysis of PANC-1 clusters, primary donor NK cells were purchased from AllCells then expanded using irradiated K562–4-1BBL-mbIL-21 (names “CSTX002”) cells kindly provided by Dr. Dean Lee according to his protocol58 (link).
+ Open protocol
+ Expand
6

Multicolor Flow Cytometry of Peritoneal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Multicolor flow cytometric analysis was performed on host cells from peritoneal fluid samples. Staining for surface markers was performed using α-CD3 APCCy7, α-CD4 FITC, α-CD8PEy7, CD11b PerCP, α-CD14 APC, CD20 PE, α-HLA-DR BV421 and α-CD45 BV500 antibodies (BD Biosciences, CA, USA). Cells (1.0 × 106) were stained for 25 min at 4°C in the dark with a cocktail of antibodies followed by fixation (eBiosciences) and wash. Appropriate fluorescence-minus-one (FMO) and/or isotype controls were used. Stained cells were acquired on a 3-laser instrument (Canto II, BD Bioscience), and data were acquired with FACSDiva 6.1.3 (BD Bioscience). The relative percentages and the absolute count of each subpopulation were determined using FlowJo 10.1 software (TreeStar San Diego CA, USA).
+ Open protocol
+ Expand
7

Comprehensive B Cell Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
LN tissue was put through a 70 μm (BD Falcon, San Jose, CA) cell strainer to obtain a single cell suspension. Cells were washed with PBS containing 0.01% NaN3 and 0.5% BSA and stained for 30 min at 4°C with directly labelled antibodies: CD45 PercP-Cy5.5, CD19 Alexa-700, CD27 APC-H7, IgD Pe-Cy7, CD20 PE, IgM FITC, CD69 PE, CD69 PerCP, CD21 APC, CD23 PE, CD25 APC, CD267 PE, BAFF-R FITC, CD16 Percp-Cy5.5, CD56 PE, CD55 PE, CD59 FITC (BD Biosciences, Breda, the Netherlands), HLA-DR Alexa-700 (eBioscience, Vienna, Austria), CD3 FITC (Sanquin, Amsterdam, the Netherlands). After incubation cells were washed and immediately analysed on a FACS CANTO II (BD Biosciences). To enable the measurement of different B cell subsets, a seven-colour FACS panel was set-up using antibodies against CD19, IgD, IgM, CD27, CD21, CD23 and CD45 (for normalization). Data were analysed using FlowJo software (Treestar, Ashland, OR, USA) and presented as frequencies, absolute numbers relative to 100 000 CD45+ lymphocytes or geometric mean fluorescence intensity (normalized on negative populations).
+ Open protocol
+ Expand
8

Immunophenotyping of Leukocyte Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
The flow cytometric analysis (FCM) of leukocyte populations were performed by three-color fluorescence methodology. Peripheral blood cells were stained with antibodies to CD45/PerCP (BD Biosciences, CA, USA), CD3/PE (BD), CD4/FITC (BD), CD8/PE (BD), CD16/FITC (Beckman Coulter, CA, USA), CD56/PE (BD), CD19/FITC (BD), CD20/PE (BD), and CD22/PE (Dako, Tokyo, Japan). After gating lymphocytes by CD45/side-scatter, expression profiling of CD markers was performed using a FACS Canto II (BD) and was analyzed using the BD FACS Diva software program (ver.6.1.2; BD).
+ Open protocol
+ Expand
9

Multicolor Flow Cytometry for Phenotypic Analyses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phenotypic analyses from patients’ blood were performed by multicolor flow cytometry of Ficoll-Hypaque-separated cell samples utilizing directly labeled mAb as described previously.17 (link) Briefly, 5 × 105 to 1 × 106 cells were incubated with murine mAb against the appropriate antigens at an optimal dilution for 20 min at 4°C. The following antibodies were used for this study: CD3 PE-Cy7, CD4 PerCP, CD8 PB, CD20 PE (BD Biosciences, Heidelberg, Germany), CD56 APC, CD279 (PD-1) AF488. If not otherwise stated antibodies were purchased from BioLegend (London, UK). Corresponding isotype-matched antibodies were used as controls. Non-specific binding was eliminated by mixing the samples with a 1:5 solution of a commercial human IgG (Octagam; Octapharma, Langenfeld, Germany). After 20 min incubation samples were washed three times in PBS/BSA, and at least 5 × 104 cells per appropriate gate were analyzed using a FACSCanto II flow cytometer with Diva software (Becton Dickinson, Heidelberg, Germany) (gating strategy: see Supplemental material Figure 1). Offline data analysis was performed by using FCS Express software V6 (Denovo Software, Glendale, CA, USA).
+ Open protocol
+ Expand
10

Flow Cytometric Analysis of T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood was stained for flow cytometry as previously described (38 (link), 68 (link)). mAbs used were as follows: CD3- FITC (clone SP34) or CD3-PerCP (clone SP34-2); CD20-PE (clone 2H7); CD8-PErCP (clone SK1) or CD8-PE (clone RPA-T8); CD4-APC (clone L200) or CD4-PerCP (clone L200); HLA-DR-PerCP (clone L243); CD95-FITC (clone DX2) or CD95-APC (clone DX2); CD28-APC (clone CD28.2) or CD28-PE (clone CD28); Ki-67–FITC (clone B56); CD25-FITC (anti–IL-2 receptor) (clone 2A3); and FoxP3–Alexa Fluor 488 (clone 259D.C7) (all from BD Biosciences). All Abs were validated and titrated using AGM PBMCs. Data were acquired with an LSR II flow cytometer (BD Biosciences) and analyzed with CellQuest software (BD Biosciences). CD4+ and CD8+ T cell percentages were obtained by first gating on lymphocytes and then on CD3+ T cells. Memory, activation, and proliferation markers were determined by gating on lymphocytes, then on CD3+ T cells, and finally on CD4+CD3+ or CD8+CD3+ T cells. Gating strategy for Tregs is presented in Supplemental Figure 6, while the gating strategy for macrophages is presented in Supplemental Figure 7.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!